# Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

> **NCT00677391** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 103 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Sibutramine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00677391
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2004-11
- **Final completion:** —
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2008-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00677391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00677391, "Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00677391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*